InMed Pharmaceuticals (INM) Amortizatization of Intangibles: 2022-2025
Historic Amortizatization of Intangibles for InMed Pharmaceuticals (INM) over the last 3 years, with Sep 2025 value amounting to $103,478.
- InMed Pharmaceuticals' Amortizatization of Intangibles rose 14.47% to $103,478 in Q3 2025 from the same period last year, while for Sep 2025 it was $334,962, marking a year-over-year decrease of 10.96%. This contributed to the annual value of $321,885 for FY2025, which is 16.38% down from last year.
- Per InMed Pharmaceuticals' latest filing, its Amortizatization of Intangibles stood at $103,478 for Q3 2025, which was up 32.11% from $78,330 recorded in Q2 2025.
- InMed Pharmaceuticals' 5-year Amortizatization of Intangibles high stood at $103,478 for Q3 2025, and its period low was $75,876 during Q4 2024.
- In the last 3 years, InMed Pharmaceuticals' Amortizatization of Intangibles had a median value of $93,085 in 2023 and averaged $90,467.
- Within the past 5 years, the most significant YoY rise in InMed Pharmaceuticals' Amortizatization of Intangibles was 14.47% (2025), while the steepest drop was 19.33% (2025).
- Quarterly analysis of 4 years shows InMed Pharmaceuticals' Amortizatization of Intangibles stood at $90,389 in 2022, then rose by 2.98% to $93,085 in 2023, then declined by 18.49% to $75,876 in 2024, then increased by 14.47% to $103,478 in 2025.
- Its Amortizatization of Intangibles was $103,478 in Q3 2025, compared to $78,330 in Q2 2025 and $77,278 in Q1 2025.